Codelivery of 1α,25-Dihydroxyvitamin D3 and CYP24A1 Inhibitor VID400 by Nanofiber Dressings Promotes Endogenous Antimicrobial Peptide LL-37 Induction.

Saved in:
Bibliographic Details
Title: Codelivery of 1α,25-Dihydroxyvitamin D3 and CYP24A1 Inhibitor VID400 by Nanofiber Dressings Promotes Endogenous Antimicrobial Peptide LL-37 Induction.
Authors: Su Y; Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States., Ganguli-Indra G; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239, United States., Bhattacharya N; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States., Logan IE; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States., Indra AK; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States.; Department of Dermatology, Oregon Health & Science University, Portland, Oregon 97239, United States., Gombart AF; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States., Wong SL; Department of Surgery-Plastic Surgery, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States., Xie J; Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.; Department of Mechanical and Materials Engineering, College of Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, United States.
Source: Molecular pharmaceutics [Mol Pharm] 2022 Mar 07; Vol. 19 (3), pp. 974-984. Date of Electronic Publication: 2022 Feb 18.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1543-8392
DOI:10.1021/acs.molpharmaceut.1c00944